QA: Werewolf Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001785530_2023_Werewolf_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001785530, Werewolf Therapeutics Inc.

  xvar xval
0 AssetsCurrent 140,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,988,000
3 remainder_Assets 11,057,000
4 LiabilitiesCurrent 23,989,000
5 LiabilitiesNoncurrent 13,919,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,696,000
9 ResearchAndDevelopmentExpense 53,761,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 18,647,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 160,245,000
1 Liabilities 37,908,000
2 Expenses 72,457,000
3 Revenues 0
4 StockholdersEquity 122,337,000
5 NetIncome -53,810,000
6 ComprehensiveNetIncome -53,810,000
7 BaseVar 144,628,500
8 EconomicCapitalRatio 1.58

Edgar->Model Mapping

Feature Distribution

Change over Time